Inventor · disambiguated record
Steven P. Seitz
Also filed as: SEITZ STEVEN P · SEITZ STEVEN PAUL
33 granted patents·2 pending applications·311 citations·filing 1981–2020
97Inventor score
Files withBRISTOL MYERS SQUIBB CO17DU PONT MERCK PHARMA5DU PONT PHARM CO3INNATE TUMOR IMMUNITY INC3FLEXUS BIOSCIENCES INC2
Top patents by PatentIndex Score
35 records- 0196US9598422B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2015·Granted Mar 21, 2017·21 cites·34 claims
- 0294US9790169B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Oct 17, 2017·19 cites·27 claims
- 0394US5874430A4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the sameDU PONT PHARM CO·Filed 1997·Granted Feb 23, 1999·87 cites·22 claims
- 0494US4567290ALeukotriene analoguesRESEARCH CORP·Filed 1983·Granted Jan 28, 1986·33 cites·1 claims
- 0592US4442099ALeukotriene analoguesRESEARCH CORP·Filed 1981·Granted Apr 10, 1984·43 cites·20 claims
- 0688US10959986B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 30, 2021·3 cites·42 claims
- 0785US9822103B2Inhibitors of lysine methyl transferaseBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 21, 2017·8 cites·7 claims
- 0882US10399932B2Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancerBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 3, 2019·3 cites·13 claims
- 0982US9675571B2Inhibitors of indoleamine 2,3-dioxygenase (IDO)BRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jun 13, 2017·6 cites·11 claims
- 1081US9738630B2Inhibitors of lysine methyl transferaseBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 22, 2017·2 cites·2 claims
- 1180US11253525B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 22, 2022·1 cites·32 claims
- 1278US9765018B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Sep 19, 2017·4 cites·11 claims
- 1378US9758492B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Sep 12, 2017·4 cites·11 claims
- 1477US8791257B2Substituted pyrrolotriazines as protein kinase inhibitorsMARKWALDER JAY A·Filed 2011·Granted Jul 29, 2014·6 cites·13 claims
- 1577US7923556B2Phenyl-substituted pyrimidine compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Apr 12, 2011·2 cites·10 claims
- 1676US12145927B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 19, 2024·1 cites·11 claims
- 1775US11203592B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Dec 21, 2021·1 cites·20 claims
- 1875US10167254B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 1, 2019·1 cites·43 claims
- 1974US11447449B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Sep 20, 2022·1 cites·9 claims
- 2074US9895330B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Feb 20, 2018·2 cites·10 claims
- 2170US5376664AUnsymmetrical mono-3-nitro bis-naphthalimides as anticancer agentsDU PONT MERCK PHARMA·Filed 1993·Granted Dec 27, 1994·11 cites·8 claims
- 2265US6559152B26-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitorsDU PONT PHARM CO·Filed 2001·Granted May 6, 2003·3 cites·8 claims
- 2362US5641782A3-aromatic and 3-heteroaromatic substituted bisnaphthalimidesDU PONT MERCK PHARMA·Filed 1995·Granted Jun 24, 1997·9 cites·16 claims
- 2461US6531477B16-substituted pyrazolo [3,4-d] pyrimidin-4-ones useful as cyclin dependent kinase inhibitorsDU PONT PHARM CO·Filed 1999·Granted Mar 11, 2003·19 cites·9 claims
- 2557US5416089APolycyclic and heterocyclic chromophores for bis-imide tumoricidalsDU PONT MERCK PHARMA·Filed 1993·Granted May 16, 1995·12 cites·15 claims
- 2656US10206893B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2017·Granted Feb 19, 2019·0 cites·23 claims
- 2754US12391675B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Aug 19, 2025·0 cites·13 claims
- 2851US7659281B2HMG-CoA reductase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Feb 9, 2010·0 cites·8 claims
- 2950US12338228B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Jun 24, 2025·0 cites·12 claims
- 3049US2006178388A1Phenyl-substituted pyrimidine compounds useful as kinase inhibitorsWROBLESKI STEPHEN T·Filed 2006·Application pending·0 cites
- 3147US5585382APolycyclic and heterocyclic chromophores for bis-imide tumoricidalsDU PONT MERCK PHARMA·Filed 1995·Granted Dec 17, 1996·7 cites·14 claims
- 3245US12037344B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2019·Granted Jul 16, 2024·0 cites·34 claims
- 3345US5359070AUnsymmetrical bis-imides as anticancer agentsDU PONT MERCK PHARMA·Filed 1993·Granted Oct 25, 1994·2 cites·4 claims
- 3444US12037323B2Uracil derivatives as Mer-AXL inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 16, 2024·0 cites·10 claims
- 3539US2004248905A16-Substituted pyrazolo [3,4-d] pyrimidin-4-ones useful as cyclin dependent kinase inhibitorsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven P. Seitz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →